Medical Device Regulatory Pathways from Asia to the EU, US and UK

We support medical device manufacturers across Asia entering the world's three most demanding regulatory markets — the EU, the United States, and the United Kingdom.

6+
Asian manufacturing markets served
3
Regulated destination markets
I–IIb
Device classifications covered
25
Years manufacturing experience
Where Manufacturers Are Based

Asian Manufacturing Bases We Serve

Regulatory intelligence and documentation support for manufacturers across Asia preparing for or maintaining access to regulated Western markets.

🇨🇳

China

Largest medical device manufacturing base in Asia
  • Thousands of manufacturers targeting EU MDR and FDA
  • Strong OEM base moving to own-brand exports
  • NMPA registration experience complementing Western pathways
EU MDRFDA 510(k)UKCA
🇮🇳

India

Fast-growing medical device export sector
  • Strong English-language regulatory capability
  • Growing diagnostics and surgical instrument exports
  • CDSCO experience alongside ISO 13485 certification
EU MDRFDAISO 13485
🇰🇷

South Korea

Sophisticated manufacturing with strong export ambition
  • Diagnostics, surgical, and rehabilitation equipment
  • MFDS-registered manufacturers entering EU and US
  • Strong IEC 60601 testing infrastructure
EU MDRFDAIEC 60601
🇹🇼

Taiwan

OEM sector moving to own-brand market entry
  • Strong contract manufacturing heritage
  • Growing own-brand regulatory submissions
  • TFDA experience complementing Western pathways
EU MDRFDAUKCA
🇵🇰

Pakistan

Sialkot — established surgical instrument manufacturing hub
  • Global leader in stainless steel surgical instruments
  • ISO 13485-certified manufacturers targeting EU and US
  • 25 years direct manufacturing experience in this sector
EU MDRFDAISO 13485
🌏

Southeast Asia

Malaysia · Vietnam · Thailand · Indonesia
  • Emerging manufacturing hubs with growing export ambition
  • Early-stage regulatory pathway planning
  • MDA, BPOM, and CDSCO experience alongside Western frameworks
EU MDRFDAPathway Planning
Destination Markets

Regulatory Pathways We Support

Three destination markets. Each with its own regulatory framework, standards requirements, and submission process.

🇪🇺

European Union

CE marking under EU MDR 2017/745 via notified body. Clinical evaluation, technical file, EUDAMED registration, UDI, and post-market surveillance for Class I through Class IIb devices.

EU MDR 2017/745 Notified Body CE Marking EUDAMED UDI PMCF
🇺🇸

United States (FDA)

FDA 510(k) substantial equivalence pathway for Class II devices. Predicate device strategy, establishment registration, device listing, and performance data presentation.

FDA 510(k) 21 CFR 820 Predicate Strategy FDA Registration Device Listing
🇬🇧

United Kingdom

UKCA marking under UK MDR 2002 as amended. MHRA registration, UK Responsible Person requirements, and post-Brexit transition for manufacturers currently holding CE marks.

UKCA UK MDR 2002 MHRA UK Responsible Person CE Transition

Ready to Discuss Your Regulatory Pathway?

Tell us your device, your manufacturing base, and your target market. We will advise on the right starting point — free and without obligation.

Send Enquiry → View Readiness Audit →